Simply Wall St.
With EPS Growth And More, Cardinal Health (NYSE:CAH) Makes An Interesting Case
📈
AI Sentiment
Highly Positive
8/10
Cardinal Health Inc. News
Latest updates and market news for CAH
16 news
Jan 20 - Jan 26, 2026
Page 1
Zacks
WST Launches Synchrony S1 Prefillable Syringe at Pharmapack
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Argus Research Adjusts Cardinal Health Price Target to $232 From $211, Maintains Buy Rating
📊
AI Sentiment
Positive
7/10
Zacks
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
âž–
AI Sentiment
Neutral
5/10
Zacks
Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock?
📈
AI Sentiment
Highly Positive
8/10
Zacks
Can Specialty Diagnostics Strength Drive Thermo Fisher's Q4 Earnings?
📈
AI Sentiment
Highly Positive
9/10
Zacks
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical and Align Technology
📈
AI Sentiment
Highly Positive
8/10
Zacks
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
📊
AI Sentiment
Positive
6/10
MT Newswires
Jefferies Adjusts Cardinal Health Price Target to $270 From $220, Maintains Buy Rating
📊
AI Sentiment
Positive
7/10
StockStory
2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm
📊
AI Sentiment
Positive
6/10
Zacks
BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Investors in Cardinal Health (NYSE:CAH) have seen massive returns of 332% over the past five years
📈
AI Sentiment
Highly Positive
9/10
Share this news page